ReciBioPharm News and Resources

LenioBio, a company specialising in cell-free protein expression technology, has entered a collaboration with ReciBioPharm, a contract development and manufacturing organisation (CDMO), to scale protein manufacturing and accelerate vaccine production. This partnership is part of an expansion of LenioBio’s CEPI-funded

ReciBioPharm, a provider of advanced therapeutics contract manufacturing services, and Hongene Biotech Corporation, known for its expertise in nucleic acid manufacturing, have announced a strategic collaboration aimed at improving gene editing drug manufacturing. This partnership will see ReciBioPharm expand its